Table of Content

  1. INTRODUCTION
    1. Study Assumptions and Market Definition
    2. Scope of the Study
  2. RESEARCH METHODOLOGY
  3. EXECUTIVE SUMMARY
  4. MARKET DYNAMICS
    1. Market Overview
    2. Market Drivers
      1. Increasing Prevalence of Diabetes in Animals
    3. Market Restraints
      1. High Cost of Treatment and Diagnostic Tools
      2. Limited Awareness and Knowledge Among Pet Owners
    4. Market Opportunity
      1. Launch of User-Friendly Products
    5. Market Trends
      1. Synthesis of Telemedicine and Digital Health Platforms
      2. Advancements in Continuous Glucose Monitoring Systems
  5. MARKET SEGMENTATION
    1. By Offering
      1. Software
      2. Services
      3. Others
    2. By Type
      1. Machine Learning
      2. Deep Learning
      3. Others
    3. By Products and Services
      1. Knowledge Management Tools
      2. Bioinformatics Platform
      3. Bioinformatics Services
    4. By Application
      1. Genomics
      2. System Biology
      3. Chemoinformatics and Drug Design
      4. Transcriptomics
      5. Metabolomics
      6. Microarrays
      7. Text mining
      8. Proteomics
      9. DNA Sequencing
      10. Others
    5. By Sector
      1. Medical Biotechnology
      2. Plant Biotechnology
      3. Forensic Biotechnology
      4. Animal Biotechnology
      5. Environmental Biotechnology
      6. Others
    6. By Key Geographic Regions
      1. North America
        1. United States
        2. Canada
        3. Mexico
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
      3. Asia Pacific
        1. China
        2. Japan
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia Pacific
      4. Middle East and Africa
        1. GCC
        2. South Africa
        3. Rest of Middle East and Africa
      5. South America
        1. Brazil
        2. Argentina
        3. Rest of South America
  6. COMPETITIVE LANDSCAPE
    1. Company Profile
      1. Eurofins Scientific
      2. Fios Genomics
      3. Insilico Medicine
      4. QIAGEN
      5. Paige Al, Inc.
      6. Thermo Fisher Scientific, Inc.
      7. Source BioScience
      8. SomaLogic Operating Co., Inc.
      9. SOPHiA Genetics
      10. Strand Lifescience
  7. MARKET OPPORTUNITIES AND FUTURE TRENDS



Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.